BR9711149A - Tratamento de respostas al-rgicas das vias respiratÄrias superiores com uma combina-Æo de antagonistas de receptor de histamina - Google Patents

Tratamento de respostas al-rgicas das vias respiratÄrias superiores com uma combina-Æo de antagonistas de receptor de histamina

Info

Publication number
BR9711149A
BR9711149A BR9711149A BR9711149A BR9711149A BR 9711149 A BR9711149 A BR 9711149A BR 9711149 A BR9711149 A BR 9711149A BR 9711149 A BR9711149 A BR 9711149A BR 9711149 A BR9711149 A BR 9711149A
Authority
BR
Brazil
Prior art keywords
treatment
combination
receptor antagonists
respiratory tract
upper respiratory
Prior art date
Application number
BR9711149A
Other languages
English (en)
Inventor
William Kreutner
John A Hey
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9711149A publication Critical patent/BR9711149A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR9711149A 1996-08-16 1997-08-13 Tratamento de respostas al-rgicas das vias respiratÄrias superiores com uma combina-Æo de antagonistas de receptor de histamina BR9711149A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (1)

Publication Number Publication Date
BR9711149A true BR9711149A (pt) 1999-08-17

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711149A BR9711149A (pt) 1996-08-16 1997-08-13 Tratamento de respostas al-rgicas das vias respiratÄrias superiores com uma combina-Æo de antagonistas de receptor de histamina

Country Status (25)

Country Link
EP (1) EP0920315B1 (pt)
JP (2) JP3638289B2 (pt)
KR (1) KR20000029975A (pt)
CN (1) CN1152682C (pt)
AR (1) AR008293A1 (pt)
AT (1) ATE314071T1 (pt)
AU (1) AU722040B2 (pt)
BR (1) BR9711149A (pt)
CA (1) CA2263163A1 (pt)
CO (1) CO4910138A1 (pt)
CZ (1) CZ43299A3 (pt)
DE (1) DE69734984D1 (pt)
HU (1) HUP9904362A3 (pt)
ID (1) ID17871A (pt)
IL (1) IL128573A0 (pt)
MY (1) MY116130A (pt)
NO (1) NO990706L (pt)
NZ (1) NZ334063A (pt)
PE (1) PE100298A1 (pt)
PL (1) PL191073B1 (pt)
SK (1) SK20099A3 (pt)
TR (1) TR199900326T2 (pt)
TW (2) TW200427450A (pt)
WO (1) WO1998006394A1 (pt)
ZA (1) ZA977263B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042379A2 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
ES2188029T3 (es) * 1997-11-07 2003-06-16 Schering Corp Fenil-alquil-imidazoles como antagonistas del receptor h3.
TW421645B (en) * 1997-11-07 2001-02-11 Schering Corp H3 receptor ligands of the phenyl-alkyl-imidazoles type
IL135727A0 (en) * 1997-11-07 2001-05-20 Schering Corp Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
JP2002527381A (ja) * 1998-10-09 2002-08-27 シェーリング コーポレイション アレルギー性疾患を処置するための組成物および方法
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
WO2001021162A2 (en) * 1999-09-22 2001-03-29 Schering Corporation Treating allergic and inflammatory conditions using desloratadine
AU3800601A (en) 2000-02-03 2001-08-14 Schering Corporation Treating allergic and inflammatory conditions
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
AU2002244271A1 (en) 2001-03-13 2002-09-24 Pharmacopeia, Inc. Non-imidazole compounds as histamine h3 antagonists
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
PE20040464A1 (es) 2002-04-18 2004-07-24 Schering Corp Benzimidazolonas sustituidas y derivados como antagonistas de histamina h3
MY135686A (en) 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
WO2007001975A1 (en) 2005-06-20 2007-01-04 Schering Corporation Piperidine derivatives useful as histamine h3 antagonists
US20110166124A1 (en) 2008-07-23 2011-07-07 Mccormick Kevin D Tricyclic spirocycle derivatives and methods of use
WO2010045306A2 (en) 2008-10-16 2010-04-22 Schering Corporation Azine derivatives and methods of use thereof
US8283360B2 (en) 2008-12-19 2012-10-09 Merck Sharp & Dohme Corp. Bicyclic heterocyclic derivatives and methods of use thereof
EP2379565A1 (en) 2008-12-19 2011-10-26 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
PT2408453T (pt) 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
EP2429530B1 (en) * 2009-05-14 2018-11-07 The General Hospital Corporation (s)-meclizine for treating ischaemia-reperfusion injury
EP2485735B1 (en) 2009-10-08 2015-07-29 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (fabp)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
JP2003095979A (ja) 2003-04-03
NO990706D0 (no) 1999-02-15
EP0920315B1 (en) 2005-12-28
AR008293A1 (es) 1999-12-29
PL331617A1 (en) 1999-08-02
CN1233179A (zh) 1999-10-27
CA2263163A1 (en) 1998-02-19
JP2000505094A (ja) 2000-04-25
WO1998006394A1 (en) 1998-02-19
DE69734984D1 (de) 2006-02-02
NO990706L (no) 1999-02-15
TW200427450A (en) 2004-12-16
PE100298A1 (es) 1999-01-11
TR199900326T2 (xx) 1999-05-21
AU3973397A (en) 1998-03-06
HUP9904362A2 (hu) 2000-11-28
AU722040B2 (en) 2000-07-20
CZ43299A3 (cs) 1999-07-14
KR20000029975A (ko) 2000-05-25
PL191073B1 (pl) 2006-03-31
JP3638289B2 (ja) 2005-04-13
CN1152682C (zh) 2004-06-09
ATE314071T1 (de) 2006-01-15
CO4910138A1 (es) 2000-04-24
NZ334063A (en) 2000-09-29
HUP9904362A3 (en) 2000-12-28
TWI221768B (en) 2004-10-11
EP0920315A1 (en) 1999-06-09
IL128573A0 (en) 2000-01-31
MY116130A (en) 2003-11-28
ID17871A (id) 1998-02-05
ZA977263B (en) 1998-02-16
SK20099A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
BR9711149A (pt) Tratamento de respostas al-rgicas das vias respiratÄrias superiores com uma combina-Æo de antagonistas de receptor de histamina
NO992371D0 (no) Engangsbleie med integrert festesone pÕ det ytre lag
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
PT832082E (pt) Derivados de n-heteroaril-piridinossulfonamidas e sua utilizacao como antagonistas de endotelina
DE69804793D1 (de) Klinisches und/oder chirurgisches trainingsgerät
DE69509765D1 (de) N-heterocyclyl sulphonamid-derivate und ihre verwendung als endothelin-antagonisten
DE69714994D1 (de) Implantierbares medizinisches gerät
DE60019844D1 (de) Implantierbare medizinische Vorrichtung mit Kondensatoranordnung und Isolierschicht
PT804419E (pt) Derivados de quinolina como antagonistas do receptor de taquiquinina nk3
GB9927056D0 (en) Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
DK0738150T3 (da) Bicykliske fibrinogene antagonister
ID19623A (id) Antagonis reseptor vitronektin
DE69728323D1 (de) Variante des humanen C3a Rezeptors; diagnostische und therapeutische Verwendungen
FR2753802B1 (fr) Interpretation de couches superieures de formation
PT869955E (pt) As n-acil-2-substituidas-4-(substituidas com residuos benzimidazolilo ou imidapiridinilo)-piperidinas como antagonistas das taquicininas
NO932391D0 (no) Angiotensin-ii reseptorantagonister for behandling av hjerterytmeforstyrrelser
EP0747055A3 (en) Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis
FI945127A (fi) Laitteisto hissin teleskooppioven ovilehtien liikkeiden synkronoimiseksi
DE59806722D1 (de) Künstlicher gelenkkopf für das menschliche hüftgelenk
DE69616364D1 (de) Endothelinrezeptorantagonisten
NO20020008D0 (no) Anvendelse av cortisol antagonister i behandling av hjertesvikt
DE59811963D1 (de) Exoprothese für das menschliche kniegelenk
MA24411A1 (fr) Muteines de l'obesite
FI953720A (fi) Neurotensiiniantagonistien käyttö diureettietan lääkkeiden valmistamiseksi
DE69634044D1 (de) Menschliches cyclin i und das dafuer kodierende gen

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]